Regulation of CLL survival by hypoxia-inducible factor and its target genes

FEBS Letters

Volumn 586, Issue 18, 2012, Pages 2906-2910

  Shachar, Idit ^a   Cohen, Sivan ^a   Marom, Ayelet ^a   Becker Herman, Shirly ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CD74; CLL; HIF; Midkine; MIF; Survival

Indexed keywords

CD74 ANTIGEN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; MIDKINE; VASCULOTROPIN;

ADAPTIVE IMMUNITY; APOPTOSIS; CANCER GROWTH; CANCER SURVIVAL; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; INNATE IMMUNITY; LEUKEMOGENESIS; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 84864922510     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.07.016     Document Type: Conference Paper

References (75)

1. M. Hallek, B.D. Cheson, D. Catovsky, F. Caligaris-Cappio, G. Dighiero, H. Dohner, P. Hillmen, M.J. Keating, E. Montserrat, K.R. Rai, and T.J. Kipps Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Blood 111 2008 5446 5456
2. F. Caligaris-Cappio, and T.J. Hamblin B-cell chronic lymphocytic leukemia: a bird of a different feather J. Clin. Oncol. 17 1999 399 408
3. F. Caligaris-Cappio, and P. Ghia Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J. Clin. Oncol. 26 2008 4497 4503
4. P. Ghia, L. Granziero, M. Chilosi, and F. Caligaris-Cappio Chronic B cell malignancies and bone marrow microenvironment Semin. Cancer Biol. 12 2002 149 155
5. P. Panayiotidis, D. Jones, K. Ganeshaguru, L. Foroni, and A.V. Hoffbrand Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro Br. J. Haematol. 92 1996 97 103
6. L. Lagneaux, A. Delforge, D. Bron, C. De Bruyn, and P. Stryckmans Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells Blood 91 1998 2387 2396
7. I.M. Pedersen, S. Kitada, L.M. Leoni, J.M. Zapata, J.G. Karras, N. Tsukada, T.J. Kipps, Y.S. Choi, F. Bennett, and J.C. Reed Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1 Blood 100 2002 1795 1801
8. J.A. Burger, N. Tsukada, M. Burger, N.J. Zvaifler, M. Dell'Aquila, and T.J. Kipps Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1 Blood 96 2000 2655 2663
9. S.N. Greer, J.L. Metcalf, Y. Wang, and M. Ohh The updated biology of hypoxia-inducible factor EMBO J. 31 2012 2448 2460
10. B. Keith, R.S. Johnson, and M.C. Simon HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression Nat. Rev. Cancer 12 2012 9 22
11. R. Chowdhury, A. Hardy, and C.J. Schofield The human oxygen sensing machinery and its manipulation Chem. Soc. Rev. 37 2008 1308 1319
12. G.L. Semenza HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus Cell 107 2001 1 3
13. A.K. Ghosh, T.D. Shanafelt, A. Cimmino, C. Taccioli, S. Volinia, C.G. Liu, G.A. Calin, C.M. Croce, D.A. Chan, A.J. Giaccia, C. Secreto, L.E. Wellik, Y.K. Lee, D. Mukhopadhyay, and N.E. Kay Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells Blood 113 2009 5568 5574
14. H. Kato, S. Tamamizu-Kato, and F. Shibasaki Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity J. Biol. Chem. 279 2004 41966 41974
15. G.A. Calin, C.G. Liu, C. Sevignani, M. Ferracin, N. Felli, C.D. Dumitru, M. Shimizu, A. Cimmino, S. Zupo, M. Dono, M.L. Dell'Aquila, H. Alder, L. Rassenti, T.J. Kipps, F. Bullrich, M. Negrini, and C.M. Croce MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Proc. Natl. Acad. Sci. U S A 101 2004 11755 11760
16. K. Parmar, P. Mauch, J.A. Vergilio, R. Sackstein, and J.D. Down Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia Proc. Natl. Acad. Sci. U S A 104 2007 5431 5436
17. B.T. Mortensen, P.O. Jensen, N. Helledie, P.O. Iversen, E. Ralfkiaer, J.K. Larsen, and M.T. Madsen Changing bone marrow micro-environment during development of acute myeloid leukaemia in rats Br. J. Haematol. 102 1998 458 464
18. J.L. Frater, N.E. Kay, C.L. Goolsby, S.E. Crawford, G.W. Dewald, and L.C. Peterson Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence Diagn. pathol. 3 2008 16
19. H.D. Skinner, J.Z. Zheng, J. Fang, F. Agani, and B.H. Jiang Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling J. Biol. Chem. 279 2004 45643 45651
20. I. Nilsson, M. Shibuya, and S. Wennstrom Differential activation of vascular genes by hypoxia in primary endothelial cells Exp. Cell Res. 299 2004 476 485
21. A.R. Kini, N.E. Kay, and L.C. Peterson Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia Leukemia 14 2000 1414 1418
22. H. Chen, A.T. Treweeke, D.C. West, K.J. Till, J.C. Cawley, M. Zuzel, and C.H. Toh In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells Blood 96 2000 3181 3187
23. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
24. F. Shojaei, and N. Ferrara Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies Drug Resist. Updat 11 2008 219 230
25. S. Dias, S.V. Shmelkov, G. Lam, and S. Rafii VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition Blood 99 2002 2532 2540
26. Y.K. Lee, T.D. Shanafelt, N.D. Bone, A.K. Strege, D.F. Jelinek, and N.E. Kay VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance Leukemia 19 2005 513 523
27. Y.K. Lee, N.D. Bone, A.K. Strege, T.D. Shanafelt, D.F. Jelinek, and N.E. Kay VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia Blood 104 2004 788 794
28. M. Winner, A.C. Koong, B.E. Rendon, W. Zundel, and R.A. Mitchell Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization Cancer Res. 67 2007 186 193
29. P.R. Reynolds, M.L. Mucenski, T.D. Le Cras, W.C. Nichols, and J.A. Whitsett Midkine is regulated by hypoxia and causes pulmonary vascular remodeling J. Biol. Chem. 279 2004 37124 37132
30. M. George, and J.H. Vaughn In vitro cell migration as a model for delayed hypersensitivity Proc. Soc. Exp. Biol. Med. 111 1962 514 521
31. M. Merk, R.A. Mitchell, S. Endres, and R. Bucala D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family Cytokine 59 2012 10 17
32. L. Leng, C.N. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, T. Delohery, Y. Chen, R.A. Mitchell, and R. Bucala MIF Signal Transduction Initiated by Binding to CD74 J. Exp. Med. 197 2003 1467 1476
33. J.A. Baugh, M. Gantier, L. Li, A. Byrne, A. Buckley, and S.C. Donnelly Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1 Biochem. Biophys. Res. Commun. 347 2006 895 903
34. M. Larsen, S. Tazzyman, E.L. Lund, N. Junker, C.E. Lewis, P.E. Kristjansen, and C. Murdoch Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner Cancer Lett. 265 2008 239 249
35. S. Oda, T. Oda, K. Nishi, S. Takabuchi, T. Wakamatsu, T. Tanaka, T. Adachi, K. Fukuda, G.L. Semenza, and K. Hirota Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner PLoS One 3 2008 e2215
36. T. Gaber, S. Schellmann, K.B. Erekul, M. Fangradt, K. Tykwinska, M. Hahne, P. Maschmeyer, M. Wagegg, C. Stahn, P. Kolar, R. Dziurla, M. Lohning, G.R. Burmester, and F. Buttgereit Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia J. Immunol. 186 2011 764 774
37. P. Stumptner-Cuvelette, and P. Benaroch Multiple roles of the invariant chain in MHC class II function Biochim. Biophys. Acta. 1542 2002 1 13
38. K. Meyer-Siegler, and P.B. Hudson Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases Urology 48 1996 448 452
39. H. Bando, G. Matsumoto, M. Bando, M. Muta, T. Ogawa, N. Funata, J. Nishihira, M. Koike, and M. Toi Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread Jpn. J. Cancer Res. 93 2002 389 396
40. I. Binsky, M. Haran, D. Starlets, Y. Gore, F. Lantner, N. Harpaz, L. Leng, D.M. Goldenberg, L. Shvidel, A. Berrebi, R. Bucala, and I. Shachar IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival Proc. Natl. Acad. Sci. U S A 104 2007 13408 13413
41. J. Nishihira, T. Ishibashi, T. Fukushima, B. Sun, Y. Sato, and S. Todo Macrophage migration inhibitory factor (MIF): its potential role in tumor growth and tumor-associated angiogenesis Ann. N.Y. Acad. Sci. 995 2003 171 182
42. J. Chesney, C. Metz, M. Bacher, T. Peng, A. Meinhardt, and R. Bucala An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma Mol. Med. 5 1999 181 191
43. K.L. Meyer-Siegler, E.C. Leifheit, and P.L. Vera Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells BMC Cancer. 4 2004 34 45
44. S. Ishigami, S. Natsugoe, K. Tokuda, A. Nakajo, H. Iwashige, K. Aridome, S. Hokita, and T. Aikou Invariant chain expression in gastric cancer Cancer Lett. 168 2001 87 91
45. A.N. Young, M.B. Amin, C.S. Moreno, S.D. Lim, C. Cohen, J.A. Petros, F.F. Marshal, and A.S. Neish Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers Am. J. Pathol. 158 2001 1639 1651
46. H.L. Ioachim, S.E. Pambuccian, M. Hekimgil, F.R. Giancotti, and B.H. Dorsett Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications Am. J. Surg. Pathol. 20 1996 64 71
47. M.W. Datta, A. Shahsafaei, L.M. Nadler, G.J. Freeman, and D.M. Dorfman Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms Appl. Immunohistochem. Mol. Morphol. 8 2000 210 215
48. R. Lazova, R. Moynes, D. May, and G. Scott LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma Cancer 79 1997 2115 2124
49. F. Narni, J. Kudo, W. Mars, B. Calabretta, D.L. Florine, B. Barlogie, and G.F. Saunders HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia Blood 68 1986 372 377
50. H. Veenstra, P. Jacobs, and E.B. Dowdle Abnormal association between invariant chain and HLA class II alpha and beta chains in chronic lymphocytic leukemia Cell Immunol. 171 1996 68 73
51. Y. Mizue, J. Nishihira, T. Miyazaki, S. Fujiwara, M. Chida, K. Nakamura, K. Kikuchi, and M. Mukai Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes Int. J. Mol. Med. 5 2000 397 403
52. D. Starlets, Y. Gore, I. Binsky, M. Haran, N. Harpaz, L. Shvidel, S. Becker-Herman, A. Berrebi, and I. Shachar Cell Surface CD74 initiates a signaling cascade leading to cell proliferation and survival Blood 107 2006 4807 4816
53. Y. Gore, D. Starlets, N. Maharshak, S. Becker-Herman, U. Kaneyuki, L. Leng, R. Bucala, and I. Shachar Macrophage migration inhibitory factor (MIF) induces B cell survival by activation of a CD74/CD44 receptor complex J. Biol. Chem. 283 2008 2784 2792
54. F. Lantner, D. Starlets, Y. Gore, L. Flaishon, A. Yamit-Hezi, R. Dikstein, L. Leng, R. Bucala, Y. Machluf, M. Oren, and I. Shachar CD74 induces TAp63 expression leading to B cell survival Blood 110 2007 4303 4311
55. A. Sapoznikov, Y. Pewzner-Jung, V. Kalchenko, R. Krauthgamer, I. Shachar, and S. Jung Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches Nat. Immunol. 9 2008 388 395
56. M. Gordin, M. Tesio, S. Cohen, Y. Gore, F. Lantner, L. Leng, R. Bucala, and I. Shachar C-Met and Its Ligand Hepatocyte Growth Factor/Scatter Factor Regulate Mature B Cell Survival in a Pathway Induced by CD74 J. Immunol. 185 2010 2020 2031
57. C.P. Chappell, and E.A. Clark Survival niches: B cells get MIFed as well as BAFFled by dendritic cells Immunol. Cell Biol. 86 2008 487 488
58. T.D. Shanafelt, S.M. Geyer, N.D. Bone, R.C. Tschumper, T.E. Witzig, G.S. Nowakowski, C.S. Zent, T.G. Call, B. LaPlant, G.W. Dewald, D.F. Jelinek, and N.E. Kay CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential Br. J. Haematol. 140 2008 537 546
59. V. Gattei, P. Bulian, M.I. Del Principe, A. Zucchetto, L. Maurillo, F. Buccisano, R. Bomben, M. Dal-Bo, F. Luciano, F.M. Rossi, M. Degan, S. Amadori, and G. Del Poeta Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia Blood 111 2008 865 873
60. D. Rossi, A. Zucchetto, F.M. Rossi, D. Capello, M. Cerri, C. Deambrogi, S. Cresta, S. Rasi, L. De Paoli, C.L. Bodoni, P. Bulian, G. Del Poeta, M. Ladetto, V. Gattei, and G. Gaidano CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia Haematologica Hematology J. 93 2008 1575 1579
61. I. Binsky, F. Lantner, V. Grabovsky, N. Harpaz, L. Shvidel, A. Berrebi, D.M. Goldenberg, L. Leng, R. Bucala, R. Alon, M. Haran, and I. Shachar TAp63 regulates VLA-4 expression and CLL cell migration to the BM in a CD74 dependent manner J. Immunol. 184 2010 4761 4769
62. T. Muramatsu Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases Proceedings of the Japan Academy, Series B. 86 2010 410 425
63. T. Muramatsu The Midkine Family of Growth/Differentiation Factors Dev. Growth Differ. 36 1994 1 8
64. W. Tokuyama, T. Mikami, M. Fujiwara, T. Matsui, and I. Okayasu Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones Pathol. Int. 57 2007 260 267
65. T. Nakanishi, K. Kadomatsu, T. Okamoto, K. Ichihara-Tanaka, T. Kojima, H. Saito, Y. Tomoda, and T. Muramatsu Expression of syndecan-1 and-3 during embryogenesis of the central nervous system in relation to binding with midkine J. Biochem. 121 1997 197
66. N. Maeda, K. Ichihara-Tanaka, T. Kimura, K. Kadomatsu, T. Muramatsu, and M. Noda A receptor-like protein-tyrosine phosphatase PTP zeta/RPTP beta binds a heparin-binding growth factor midkine - Involvement of arginine 78 of midkine in the high affinity binding to PTP zeta J. Biol. Chem. 274 1999 12474 12479
67. H. Muramatsu, K. Zou, N. Sakaguchi, S. Ikematsu, S. Sakuma, and T. Muramatsu LDL receptor-related protein as a component of the midkine receptor Biochem. Biophys. Res. Commun. 270 2000 936 941
68. G.E. Stoica, A. Kuo, C. Powers, E.T. Bowden, E.B. Sale, A.T. Riegel, and A. Wellstein Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types J. Biol. Chem. 277 2002 35990 35998
69. H. Muramatsu, P. Zou, H. Suzuki, Y. Oda, G.Y. Chen, N. Sakaguchi, S. Sakuma, N. Maeda, M. Noda, Y. Takada, and T. Muramatsu Alpha 4 beta 1-and alpha 6 beta 1-integrins are functional receptors for midkine, a heparin-binding growth factor J. Cell Sci. 117 2004 5405 5415
70. M. Take, J. Tsutsui, H. Obama, M. Ozawa, T. Nakayama, I. Maruyama, T. Arima, and T. Muramatsu Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM) J. Biochem. 116 1994 1063
71. Y. Shibata, T. Muramatsu, M. Hirai, T. Inui, T. Kimura, H. Saito, L.M. McCormick, G. Bu, and K. Kadomatsu Nuclear targeting by the growth factor midkine Mol. Cell. Biol. 22 2002 6788
72. T. Ohuchida, K. Okamoto, K. Akahane, A. Higure, H. Todoroki, Y. Abe, M. Kikuchi, S. Ikematsu, T. Muramatsu, and H. Itoh Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity Cancer 100 2004 2430 2436
73. H. Jono, and Y. Ando Midkine: a novel prognostic biomarker for cancer Cancer 2 2010 624 641
74. K. Kadomatsu, M. Hagihara, S. Akhter, Q. Fan, H. Muramatsu, and T. Muramatsu Midkine induces the transformation of NIH3T3 cells Br. J. Cancer 75 1997 354
75. S. Cohen, O.Y. Shoshana, E. Zelman-Toister, N. Maharshak, I. Binsky-Ehrenreich, M. Gordin, I. Hazan-Halevy, Y. Herishanu, L. Shvidel, M. Haran, L. Leng, R. Bucala, S. Harroch, and I. Shachar The Cytokine Midkine and Its Receptor RPTPzeta Regulate B Cell Survival in a Pathway Induced by CD74 J. Immunol. 188 2012 259 269